| Date Filed | Type | Description |
| 03/29/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/13/2023 |
4
| Ward Shane (COO & CLO) has filed a Form 4 on Cidara Therapeutics, Inc.|
Txns:
| Sold 4,329 shares
@ $1.53, valued at
$6.6k
|
|
| 04/04/2022 |
4
| Ward Shane (CHIEF LEGAL OFFICER) has filed a Form 4 on Cidara Therapeutics, Inc.|
Txns:
| Granted 35,000 shares
@ $0
Granted 69,027 shares
@ $0
Paid exercise price by delivering 23,122 shares
@ $0.83, valued at
$19.2k
Granted 70,000 options to buy
@ $0.83, valued at
$58.1k
|
|
| 08/27/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/27/2021 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 06/02/2020 |
4
| Ward Shane (Sr VP and Chief Legal SO) has filed a Form 4 on BELLICUM PHARMACEUTICALS, INC|
Txns:
| Paid exercise price by delivering 107 shares
@ $7.63, valued at
$816.4 |
|
| 04/09/2020 |
4
| Ward Shane (Sr. VP and General Counsel) has filed a Form 4 on BELLICUM PHARMACEUTICALS, INC|
Txns:
| Granted 21,864 restricted stock units
@ $0 |
|
| 02/04/2020 |
4
| Ward Shane (Sr. VP and General Counsel) has filed a Form 4 on BELLICUM PHARMACEUTICALS, INC|
Txns:
| Granted 410,000 options to buy
@ $1.36, valued at
$557.6k
|
|
| 08/30/2019 |
4
| Ward Shane (Sr. VP and General Counsel) has filed a Form 4 on BELLICUM PHARMACEUTICALS, INC|
Txns:
| Bought 8,000 shares
@ $1.2277, valued at
$9.8k
|
|
| 06/11/2019 |
4
| Ward Shane (Sr. VP and General Counsel) has filed a Form 4 on BELLICUM PHARMACEUTICALS, INC|
Txns:
| Granted 45,000 options to buy
@ $1.87, valued at
$84.2k
|
|
| 05/30/2019 |
4
| Ward Shane (Sr. VP and General Counsel) has filed a Form 4 on BELLICUM PHARMACEUTICALS, INC|
Txns:
| Paid exercise price by delivering 1,065 shares
@ $2.09, valued at
$2.2k
|
|
| 02/05/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/29/2018 |
4
| Ward Shane (Sr. VP and General Counsel) has filed a Form 4 on BELLICUM PHARMACEUTICALS, INC|
Txns:
| Granted 10,000 shares
@ $0
Granted 120,000 options to buy
@ $7.95, valued at
$954k
|
|
| 05/29/2018 |
3
| Ward Shane (Sr. VP and General Counsel) has filed a Form 3 on BELLICUM PHARMACEUTICALS, INC |
| 02/12/2018 |
4
| Ward Shane (SVP and General Counsel) has filed a Form 4 on Versartis, Inc.|
Txns:
| Sold 4,118 shares
@ $1.8, valued at
$7.4k
|
|
| 12/22/2017 |
4
| Ward Shane (SVP and General Counsel) has filed a Form 4 on Versartis, Inc.|
Txns:
| Granted 93,100 shares
@ $0 |
|
| 11/29/2017 |
4
| Ward Shane (SVP and General Counsel) has filed a Form 4 on Versartis, Inc.|
Txns:
| Granted 20,000 shares
@ $0 |
|
| 10/23/2017 |
4
| Ward Shane (SVP and General Counsel) has filed a Form 4 on Versartis, Inc.|
Txns:
| Sold 776 shares
@ $2.55, valued at
$2k
|
|
| 10/10/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/15/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 01/31/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |